Effect of Streptozotocin (STZ) on Pancreatic Carcinogenisis

Chennuru Veeranjaneyulu and Gangapatnam Subrahmanayam
Additional contact information
Chennuru Veeranjaneyulu: Department of Advanced ResearchCenter, Narayana Medical Institutions, India
Gangapatnam Subrahmanayam: Director & Interventional Cardiologist, Narayana Medical Institutions, India

Cancer Therapy & Oncology International Journal, 2017, vol. 7, issue 5, 82-83

Abstract: Streptozotocin (STZ) is a one of the greatest indication of diabetogenic agent in experimental Animal works and also it can be used for therapeutic treatment of cancer in human beings. It’s main occupation toxic and necrotic cell death. Its use is normally limited to patients whose cancer cannot be removed by surgery. In these patients, streptozotocin can reduce the tumor size and moderate symptoms. Streptozotocin doesn’t have an effect on the pancreatic beta cells of humans when utilized in the treatment of islet-cell carcinomas and malignant carcinoid tumors in humans.

Keywords: juniper publishers:oncology journals; oncology research journals; oncology journal articles; oncology and cancer case reports; oncology journal of clinical and experimental cancer research; open access; open access journals; Oncology International Journal; juniper publishers reivew (search for similar items in EconPapers)
Date: 2017
References: View complete reference list from CitEc
Citations:

Downloads: (external link)
https://juniperpublishers.com/ctoij/pdf/CTOIJ.MS.ID.555725.pdf (application/pdf)
https://juniperpublishers.com/ctoij/CTOIJ.MS.ID.555725.php (text/html)

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:adp:jctoij:v:7:y:2017:i:5:p:82-83

DOI: 10.19080/CTOIJ.2017.07.555725

Access Statistics for this article

Cancer Therapy & Oncology International Journal is currently edited by Sophia Mathis

More articles in Cancer Therapy & Oncology International Journal from Juniper Publishers Inc.
Bibliographic data for series maintained by Robert Thomas ().